作者: David L. Greenspan , Marina Cardillo , Diane D. Davey , Debra S. Heller , Ann T. Moriarty
DOI: 10.1097/01.LGT.0000210130.01016.AD
关键词: Histiocyte 、 Transvaginal ultrasound 、 Hormone replacement therapy (menopause) 、 Hormonal therapy 、 Medicine 、 Stromal cell 、 Prospective cohort study 、 Cervical cytology 、 Bethesda system 、 Gynecology
摘要: The 2001 Bethesda System for Reporting Cervical Cytology recommends reporting benign exfoliated endometrial cells in women age 40 and older, a review of the literature supports this recommendation. Stromal histiocytes do not need to be reported. effect hormonal therapy on shedding is reviewed. Clinical information should provided laboratory so that appropriate educational notes can appended cytology report. Benign premenopausal first half cycle are associated with significant pathology such additional evaluation. Significant also unlikely second evaluation may required unless clinically indicated. Initial other include either sampling or transvaginal ultrasound. Atypical higher rate lead Additional prospective studies management patients Pap tests needed.